Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
Intrinsic Value
Shanghai Labway Clinical Laboratory Co., Ltd. engages in the provision of medical and pathological examination services. [ Read More ]
The intrinsic value of one
Shanghai Labway Clinical Laboratory Co Ltd
stock under the Base Case scenario is
48.45
CNY.
Compared to the current market price of 10.2 CNY,
Shanghai Labway Clinical Laboratory Co Ltd
is
Undervalued by 79%.
Shanghai Labway Clinical Laboratory Co Ltd's market capitalization is 4.1B CNY.
Shanghai Labway Clinical Laboratory Co Ltd stock price is 10.2 CNY.
Shanghai Labway Clinical Laboratory Co Ltd stock price (10.2 CNY) is 79% less than its Intrinsic Value (48.45 CNY).
Shanghai Labway Clinical Laboratory Co Ltd stock price (10.2 CNY) is 88% less than its DCF Value (87.12 CNY). Open DCF Valuation
Shanghai Labway Clinical Laboratory Co Ltd stock (9.78 CNY) is 4% less than its price (10.2 CNY). Open Relative Valuation
Shanghai Labway Clinical Laboratory Co Ltd.
Shanghai Labway Clinical Laboratory Co Ltd has positive Net Income for the last twelve months.
Shanghai Labway Clinical Laboratory Co Ltd has positive Free Cash Flow for the last twelve months.
Shanghai Labway Clinical Laboratory Co Ltd has positive Operating Income for the last twelve months.
Shanghai Labway Clinical Laboratory Co Ltd's ROE (Return on Equity) for the past 12 months is very low and is equal to 1%.
Shanghai Labway Clinical Laboratory Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to 0%.
Shanghai Labway Clinical Laboratory Co Ltd has positive three-year average ROE (Return on Equity): 17%. The company is efficient at transforming stockholders' equity into net income.
Shanghai Labway Clinical Laboratory Co Ltd's Revenue has dropped by 35% over the past 12 months.
Shanghai Labway Clinical Laboratory Co Ltd has positive Gross Profit for the last twelve months.
Shanghai Labway Clinical Laboratory Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (656m CNY) than debt (404m CNY).
Shanghai Labway Clinical Laboratory Co Ltd has positive three-year average ROIC (Return on Invested Capital): 24%. The company is efficient at using invested capital to generate operating income.
Shanghai Labway Clinical Laboratory Co Ltd's long-term assets (3B CNY) exceed its long-term liabilties (1B CNY).
Shanghai Labway Clinical Laboratory Co Ltd's short-term assets (2B CNY) exceed its short-term liabilties (768m CNY).
Shanghai Labway Clinical Laboratory Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.21.
Shanghai Labway Clinical Laboratory Co Ltd's Altman Z-Score is very high and is equal to 4.79.
Valuation Backtest
Shanghai Labway Clinical Laboratory Co Ltd
Run backtest to discover the historical profit from buying and selling
Shanghai Labway Clinical Laboratory Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Shanghai Labway Clinical Laboratory Co Ltd
Balance Sheet Decomposition
Shanghai Labway Clinical Laboratory Co Ltd
| Current Assets | 2.5B |
| Cash & Short-Term Investments | 655.9m |
| Receivables | 1.4B |
| Other Current Assets | 417m |
| Non-Current Assets | 628.2m |
| Long-Term Investments | 14.5m |
| PP&E | 479.8m |
| Intangibles | 35.6m |
| Other Non-Current Assets | 98.3m |
| Current Liabilities | 767.7m |
| Accounts Payable | 390m |
| Accrued Liabilities | 33.2m |
| Short-Term Debt | 244.2m |
| Other Current Liabilities | 100.3m |
| Non-Current Liabilities | 382.1m |
| Long-Term Debt | 159.5m |
| Other Non-Current Liabilities | 222.6m |
Earnings Waterfall
Shanghai Labway Clinical Laboratory Co Ltd
|
Revenue
|
2.4B
CNY
|
|
Cost of Revenue
|
-1.6B
CNY
|
|
Gross Profit
|
735.4m
CNY
|
|
Operating Expenses
|
-666m
CNY
|
|
Operating Income
|
69.4m
CNY
|
|
Other Expenses
|
-57.3m
CNY
|
|
Net Income
|
12.1m
CNY
|
Free Cash Flow Analysis
Shanghai Labway Clinical Laboratory Co Ltd
Profitability Score
Profitability Due Diligence
Shanghai Labway Clinical Laboratory Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Shanghai Labway Clinical Laboratory Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai Labway Clinical Laboratory Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Shanghai Labway Clinical Laboratory Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai Labway Clinical Laboratory Co Ltd
Shareholder Return
Price
Shanghai Labway Clinical Laboratory Co Ltd
| Average Annual Return | 21.14% |
| Standard Deviation of Annual Returns | 84.9% |
| Max Drawdown | -85% |
| Market Capitalization | 4.1B CNY |
| Shares Outstanding | 400 516 992 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Shanghai Labway Clinical Laboratory Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Shanghai Labway Clinical Laboratory Co., Ltd. engages in the provision of medical and pathological examination services. The company is headquartered in Shanghai, Shanghai and currently employs 1,522 full-time employees. The company went IPO on 2021-09-13. The firm's businesses include medical testing and pathological diagnosis services and the sales of in vitro diagnosis product. The medical examination and pathological diagnosis services include pathological diagnosis, molecular examination, biochemical examination, immune examination, microbial examination, clinical basic examination and physical and chemical examination. The in vitro diagnostic products sales include in vitro diagnostic instruments, reagents and related accessories and consumables.
Contact
IPO
Employees
Officers
The intrinsic value of one
Shanghai Labway Clinical Laboratory Co Ltd
stock under the Base Case scenario is
48.45
CNY.
Compared to the current market price of 10.2 CNY,
Shanghai Labway Clinical Laboratory Co Ltd
is
Undervalued by 79%.
You don't have any saved screeners yet
